

Alzheimer’s Disease Blog Posts (Part I)
Explore a wide range of content related to Alzheimer’s Disease research into potential therapies, such as Neurofilament-Light Chain, Flortaucipir PET, exRNA Markers, Protein Shapes and more.

Alzheimer’s Disease Blog Posts (Part II)
Enjoy a series of short articles related to Alzheimer’s Disease research into potential therapies, such as Tau Propogation, MTBR-Tau-243, Marmosets as Primate Models, Retinal Scans, 13 newly discovered Alzheimer’s Genes and more.

Missouri Clinical Site Overview
The QPS Clinical Research site in Springfield, MO, USA is an impressive facility in a great location. If you are a sponsor looking for a site, or a potential study subject looking to participate in a clinical trial, this interactive resource provides a closer look at the facility and surrounding area.

QPS Delaware Headquarters Site Visit Information
The QPS Headquarters in Newark, DE is a comprehensive preclinical research facility, performing DMPK, Bioanalysis and Translational Medicine studies. This interactive resource provides a range of information that will support your visit to our site.

Clinical Study Operations & FAQ Related to COVID-19
Explore the QPS strategies to ensure the safety of staff and study subjects in our global clinical study sites and facilities in light of the ongoing COVID-19 pandemic and learn the answers to frequently asked questions on this topic.

Coronavirus Blog Posts 2020
Get up to speed with a wide range of COVID-19 related insights, including Aerosolized and Airborne Particles, Progress with Testing, Vaccine Developments and FDA Guidance Documents.

Coronavirus Overview of FDA Guidelines
Since the onset of COVID-19, safeguarding staff and study subjects has been a critical component of everyday activities at QPS. Read this review of our approach and the FDA recommendations for opening a business during the current pandemic.

Immunogenicity eBook
QPS has partnered with Bioanalysis Zone and Gyros to bring you this in-depth look at the proper assessment of anti-drug antibodies (ADAs), which is fundamental to immunogenicity testing. Hear directly from Xun Wang, PhD, QPS Senior Director of Bioanalysis in the Department of Translational Medicine (TLM).